The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Vermox 100mg/5ml Oral Suspension



JNTL Consumer Health I (Ireland) LimitedPA23490/026/001

Main Information

Trade NameVermox 100mg/5ml Oral Suspension
Active SubstancesMebendazole
Dosage FormOral suspension
Licence HolderJNTL Consumer Health I (Ireland) Limited
Licence NumberPA23490/026/001

Group Information

ATC CodeP02CA Benzimidazole derivatives
P02CA01 mebendazole

Status

License statusAuthorised
Licence Issued17/07/2009
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back